A case of chronic myocarditis.


Journal

Pathology international
ISSN: 1440-1827
Titre abrégé: Pathol Int
Pays: Australia
ID NLM: 9431380

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 21 04 2020
revised: 07 07 2020
accepted: 08 07 2020
pubmed: 28 7 2020
medline: 17 8 2021
entrez: 28 7 2020
Statut: ppublish

Résumé

Chronic myocarditis is sometimes difficult to diagnose using several clinical diagnostic modalities. A 43-year-old Japanese man was admitted to our hospital with heart failure due to a diffusely hypokinetic left ventricle. No abnormal accumulation was seen on

Identifiants

pubmed: 32716103
doi: 10.1111/pin.12989
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

793-797

Informations de copyright

© 2020 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.

Références

Imanaka-Yoshida K. Inflammation in myocardial disease: From myocarditis to dilated cardiomyopathy. Pathol Int. 2020; 70: 1-11.
Caforio AL, Pankuweit S, Arbustini E et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013; 34: 2636-48.
Japanese Circulation Society (JCS). Task force committee on chronic myocarditis. Guideline for diagnosing chronic myocarditis. Jpn Circ J 1996; 60: 263-64.
JCS Joint Working Group. Guidelines for diagnosis and treatment of myocarditis (JCS 2009): Digest version. Circ J 2011; 75: 734-43.
Morimoto S, Hiramitsu S, Yamada K et al. Clinical and pathologic features of chronic myocarditis: Four autopsy cases presenting as dilated cardiomyopathy in life. Am J Cardiovasc Pathol 1992; 4: 181-91.
Okabe M, Fukuda K, Nakashima Y, Hiroki T, Arakawa K, Kikuchi M. Lymphocytic active myocarditis characterized by numerous clusters of lymphocytes: A chronic variant of myocarditis? Am Heart J 1992; 123: 128-316.
Nishikawa T, Sekiguchi M, Ishibashi-Ueda H. More than 50 years after Konno's development of the endomyocardial biopsy. Int Heart J 2017; 58: 840-46.
Ishibashi-Ueda H, Matsuyama TA, Ohta-Ogo K, Ikeda Y. Significance and value of endomyocardial biopsy based on our own experience. Circ J. 2017; 81: 417-26.
Tschöpe C, Van Linthout S, Spillmann F et al. Targeting CD20+ B-lymphocytes in inflammatory dilated cardiomyopathy with rituximab improves clinical course: A case series. Eur Heart J Case Rep 2019; 3: 1-6.
Chen W, Jeudy J. Assessment of myocarditis: Cardiac MR, PET/CT, or PET/MR? Curr Cardiol Rep 2019; 21: 76.
Lurz P, Eitel I, Adam J et al. Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. JACC Cardiovasc Imaging 2012; 5: 513-24.
Richardson P, McKenna W, Bristow M et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996; 93: 841-42.
Trachtenberg BH, Hare JM. Inflammatory cardiomyopathic syndromes. Circ Res 2017; 121: 803-18.
Felker GM, Thompson RE, Hare JM et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077-84.
Heymans S, Eriksson U, Lehtonen J, Cooper LT Jr. The quest for new approaches in myocarditis and inflammatory cardiomyopathy. J Am Coll Cardiol 2016; 68: 2348-64.
Maisch B, Pankuweit S. Inflammatory dilated cardiomyopathy: Etiology and clinical management. Herz. 2020; 45: 221-29.
Shintaku M, Uchiyama K, Kobayashi Y. Chronic myocarditis with a long clinical course: Report of an autopsy case of probable autoimmune myocarditis. Pathol Int. 2017; 67: 521-25.
Kishimoto C, Takamatsu N, Ochiai H, Kuribayashi K. Nucleotide differences of coxsackievirus B3 and chronic myocarditis. Heart Vessels. 2015; 30: 126-35.

Auteurs

Hiroaki Kawano (H)

Department of Cardiovascular Medicine, Nagasaki University Hospital, Nagasaki, Japan.

Keita Iyama (K)

Department of Cardiovascular Medicine, Nagasaki University Hospital, Nagasaki, Japan.

Kuniko Abe (K)

Department of Pathology, Nagasaki University Hospital, Nagasaki, Japan.

Mitsuaki Ishijima (M)

Department of Cardiovascular Medicine, Nagasaki University Hospital, Nagasaki, Japan.

Tsuyoshi Yonekura (T)

Department of Cardiovascular Medicine, Nagasaki University Hospital, Nagasaki, Japan.

Seiji Koga (S)

Department of Cardiovascular Medicine, Nagasaki University Hospital, Nagasaki, Japan.

Satoshi Ikeda (S)

Department of Cardiovascular Medicine, Nagasaki University Hospital, Nagasaki, Japan.

Koji Maemura (K)

Department of Cardiovascular Medicine, Nagasaki University Hospital, Nagasaki, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH